Clinical Research Directory
Browse clinical research sites, groups, and studies.
Brain NAD in Alzheimer's Disease
Sponsor: Florida Atlantic University
Summary
The goal of this observational study is to learn about the levels of nicotinamide adenine dinucleotide (NAD) in the brains of people with Alzheimer's disease. The study aims to determine if brain NAD levels are lower in people with Alzheimer's disease compared with people of the same age group who do not have Alzheimer's disease. Participants with or without Alzheimer's disease will have a brain imaging session where NAD will be measured using magnetic resonance spectroscopy (MRS). Eight months later, they will have a second, similar, brain imaging session.
Official title: Measurement of Brain NAD Levels in Alzheimer's Patients and Control Subjects by 1H-MRS
Key Details
Gender
All
Age Range
65 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
20
Start Date
2026-03-18
Completion Date
2027-06-01
Last Updated
2026-03-24
Healthy Volunteers
Yes
Conditions
Locations (1)
FAU Clinical Research Unit
Boca Raton, Florida, United States